Patents Assigned to AVOLYNT
  • Method for treating post-prandial hypoglycemia
    Patent number: 11596644
    Abstract: Disclosed herein are methods, sodium-dependent glucose transporter (SGLT)1 compounds and compositions for the treatment of postprandial hypoglycemia, postprandial hypoglycemia that occurs as a consequence of gastric surgery.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: March 7, 2023
    Assignees: AVOLYNT, KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: William Wilkison, Bentley Cheatham, James T. Green